Finance beat
The Earnings beat on Finance tracks 585 verified stories, with 47 clearing multi-source corroboration in the last 7 days at mean impact 5.1/10 — live SQLite counts, not editorial weighting.
50 stories
Beat pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 9 percentage points.
Stories appear on this page because our classification stage assigned them this category as their primary topic — each story receives exactly one category per niche, chosen from a fixed list, so a story that touches both a funding round and a product launch in the same week sorts into whichever category best matches its dominant subject, not both. This keeps each category page focused on one beat rather than a blend of unrelated developments, and applies the same source-verification standard used across every story on this site. Sentiment measures the directional read of each development for this category specifically, not the tone of the reporting, and impact weights how consequential a development is — regulatory, financial, or operational — rather than how widely it was syndicated across outlets.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Beat actors
Entities appearing in at least two verified earnings stories on this desk — ranked by mention count, not editorial preference.
CEO Michael Miebach says cybersecurity is Mastercard's fastest-growing business, backed by a $15.6 trillion cyber-risk projection and a proprietary transaction-data moat. The interview, published after Q2 earnings, signals where future revenue could compound.
Source: Motley Fool Staff (us) · finance.yahoo.com
Moleculin Biotech shares rose 9.6% to $0.57 after a narrower-than-expected Q2 loss, yet the stock remains down roughly 97% from its 12-month high, with analysts' average $22.00 target detached from reality. The real signal for traders is a 2.3x volume surge, a beta of 1.83, and thin 15.52% institutional ownership.
Meta trades below $600 as 2026 capex guidance of $130B-$145B pressures profitability. A proposed AI cloud could monetize excess compute but hasn't yet produced disclosed revenue, leaving investors facing near-term earnings declines.
Finance and markets: Oncobiologics missed EPS by $0.01 and reported $0.01M revenue, yet 104M shares traded (6x volume) as insiders bought $5.16M; Galectin missed by $0.05.
Shera Energy is guiding to 25-30% revenue and bottom-line growth in FY27, implying turnover of roughly ₹2,050-2,132 crore from ₹1,640 crore in FY26. Capacity expansion into solar ribbon and CTC conductors aligns with India's power and renewable capex cycle, but certification timelines and raw-material inflation are key earnings risks.
EPL raised near-term revenue guidance to 16-18% after 25% June-quarter top-line growth, with Blackstone backing and a proposed $2 billion Indovida merger shaping the equity story.
Source: thehindubusinessline.com · economictimes.indiatimes.com
Replimune missed consensus EPS by $0.03 but held near its 52-week high at $14.97. Insider sales totaling over $650,000 were tax-related, while analyst targets now range up to $17, creating a gap between the $11.86 average target and the stock price.
Lantern Pharma missed quarterly EPS estimates by $0.19, but shares rose 0.76% to $2.65 on double average volume. The micro-cap trades below both moving averages with a beta of 2.34 and a Sell consensus. Institutional accumulation is scattered and small.
Silexion beat consensus by $16.03 with a ($5.17) EPS, yet shares fell to $0.42. With volume at 2x average, a 52-week high of $80, and Hold consensus, the microcap has shed nearly all value.
Sinopec Engineering (Group) reported unaudited H1 2026 revenue of RMB35.62 billion, up 12.7% year-on-year, but gross profit grew only 5.2%, compressing margins. New contracts of RMB51.9 billion signal strong backlog, and the board maintained a 50% payout with an RMB0.127 interim dividend.
Source: finanznachrichten.de · finanzen.ch
Globant reported EPS of $1.40, missing consensus by $0.10, while revenue of $614.42 million slightly beat estimates but was flat year over year. Shares fell 8.9% to $37.35 as analysts lowered price targets. The company reiterated FY2026 EPS guidance of $5.75-$6.15 and Q3 guidance of $1.43.
Source: themarketsdaily.com · dailypolitical.com
Mistras Group posted a record second-quarter adjusted EBITDA of $25.8 million on 4.2% revenue growth, while TransAct Technologies raised full-year guidance after underlying sales rose 8% excluding tariff refunds.
Source: tickerreport.com · dailypolitical.com
Heritage Global posted a Q2 operating loss of $20.9M after recording $21.7M in non-cash charges to exit its specialty lending business. Revenue fell to $12.3M, and management is redirecting capital toward industrial and financial assets platforms including DebtX and Boston Note Company.
Source: dailypolitical.com · tickerreport.com
Laser Photonics reports Q2 net sales of $1.8M, up 97% sequentially, with gross margin improving to 8.4% from negative 42.4%. The company's anti-drone Laser Shield system is advancing through U.S. defense evaluations, while Zeo and Clene also posted Q2 updates in the same reporting window.
Smith-Midland's latest quarterly results show a profitable small-cap with an almost 20% return on equity and very low leverage, even as the stock trades about 35% below its 52-week high. The $0.26 EPS and $23.36 million revenue figure, combined with rising institutional holdings, make it a watch item for value-oriented small-cap investors. However, the stock remains below its 50-day and 200-day moving averages, keeping the technical picture cautious.
Source: MarketBeat · themarketsdaily.com
Safe Pro Group reported a quarterly EPS of -$0.15, one cent below consensus, but shares soared 37.7% on 21x average volume. The move pushed market cap to $128.89M even as negative net margin widened to 800.91%.
Source: MarketBeat · themarketsdaily.com
Mako Mining posted Q2 2026 adjusted EBITDA of $31.7 million and EPS of $0.16 on record revenue of $62.6 million, driven by realized gold prices of $4,201 per ounce against AISC of $2,286. The company says its $112 million cash position can fund remaining development without external capital and hints at upcoming shareholder capital returns.
Source: newjerseytelegraph.com · finanznachrichten.de
Q2 2026 earnings show Acacia Research's record $114.6M IP-settlement revenue countered by a Life Sciences write-down, while Dutch Bros grew 32.5%. Datadog, MP Materials, and Maravai add cloud, rare-earth, and biotech signals for investors.
Source: Yahoo! News · Fool
Nutex Health posted $65.8M in net income and $9.38 EPS despite revenue falling 13.6% to $210.8M, driven by a retroactive HaloMD contract amendment and federal fee cuts. Across the Q2 cluster, Omada raised guidance, Arteris grew ACV plus royalties 44%, and Grindr reported AI-driven cost avoidance.
Q1 FY2027 earnings across semiconductors, digital trust, and private markets show AI infrastructure spending accelerating while consumer cybersecurity and private wealth fundraising hit records. Microchip's data center revenue nearly doubled and its inventory correction is complete, with Gen Digital and StepStone adding multi-billion-dollar momentum.
Source: Motley Fool Transcribing (us) · fool.com
SUI Group's Q2 2026 call revealed a digital asset treasury generating $1.2M in revenue while absorbing $16.6M in noncash losses. The 0.72x mNAV ratio signals shares trading below underlying asset value.
Source: Motley Fool Transcribing (us) · fool.com
Bridgeline's Q3 FY26 results show total revenue up 2.6% to $3.9 million, with core product revenue up 9.1% and now 62% of total. The mix shift toward higher-quality recurring revenue is the key investor takeaway.
Source: californiatelegraph.com · tennesseedaily.com
Nortech grew Q2 sales 9.3% to $33.5M with 120 bps gross margin expansion, though stock comp held operating income to $623K. Andersen's 23.7% revenue growth and 20.6% organic growth provided a contrast in pricing power.
TechPrecision grew Q1 revenue 23% to $9.1 million and carries a $52.7 million funded backlog, while Cineverse used acquisitions to lift revenue 175% to $30.6 million but saw its net loss widen to $5.8 million. Finance readers should track backlog conversion, integration costs, and the path to GAAP profitability.
Source: prnewswire.com · finanznachrichten.de
Three Q2 2026 earnings releases from Eton Pharmaceuticals, Dawson Geophysical, and Jefferson Capital show strong revenue growth but uneven profitability. Finance readers should focus on revenue catalysts, margin expansion, and dividend sustainability.
New analysis of unaudited H1 2026 filings shows 12 large-cap NGX names grew combined cost of sales and OPEX 16.9% to N10.14tn, outpacing June inflation of 15.91% even as the naira firmed. Profit before tax still rose to N4.95tn from N2.84tn, but concentrated cost pressure among Oando, Seplat, Dangote Cement and MTN raises margin-sustainability questions for investors.
Source: allafrica.com · thisdaylive.com
U-Haul's Q1 FY2027 earnings declined 13.6% to $122.9 million as higher operating and interest expenses outweighed 2.8% moving revenue growth. Non-voting EPS fell to $0.63 from $0.73, while adjusted EBITDA slipped $8.5 million to $536.7 million.
Solaris reported Q2 2026 revenue of $219 million (up 12% sequentially), adjusted EBITDA of $108 million (up 30%), and non-GAAP EPS of $0.39. With $1.4 billion in liquidity and $1.3 billion in senior notes, the company is recapitalizing to fund Q4 EBITDA guidance of $100-120 million.
Digi International's fiscal Q3 shows software-led ARR scaling faster than revenue, driving 47% adjusted EBITDA growth and a 29.1% margin. Full-year guidance of $529M-$533M implies 23-24% revenue growth with further margin expansion. Finance readers should watch whether Particle and Jolt acquisition payback is sustainable.
Source: Motley Fool Transcribing (us) · fool.com
Nebius Group's Q2 revenue soared 454% to $582 million and EBITDA swung to a $236 million profit, triggering a 34% stock spike. Heavy short interest and the debate over AI infrastructure returns make this a key battleground for investors.
Duolingo lifted full-year adjusted EBITDA target to 26.5%, guided about $320M EBITDA and $375M+ FCF, repurchased $44M in stock, and grew DAUs 23%.
Seneca Foods posted a top-line beat of $405.17M, 24% above estimates, despite a $0.07 EPS miss, driving a 7.4% stock surge and Strong Buy ratings. Talkspace, meanwhile, missed on both EPS and revenue, but its stock held steady as institutional investors continued accumulating shares.
Source: themarketsdaily.com · dailypolitical.com
Shenandoah Telecommunications is poised for a financial inflection as its Glo Fiber unit surpasses 100,000 subscribers and capex declines. Q2 Glo Fiber revenue surged 33% YoY to 28% of total revenue, while churn remains low and premium speed tiers dominate additions. With positive free cash flow expected next year, the stock's transition from investment phase to cash generation could unlock significant upside for investors.
Source: tickerreport.com · finance.yahoo.com
Engineering services giants AECOM and Amentum both released disappointing FY2026 outlooks on August 10, 2026. AECOM's EPS guidance of $3.95–$4.15 was far below the $5.97 consensus, while Amentum's revenue guidance missed estimates by up to $400 million. The news sent both stocks lower, deepening recent slumps.
Source: dailypolitical.com · themarketsdaily.com
ESCO Technologies lifted its full‑year EPS forecast above analyst estimates, signaling strong margin expansion. Q4 guidance brackets consensus while management’s confidence is backed by a Q3 beat and a spotless balance sheet. With a consensus Buy rating and $410 average target, the raised outlook may fuel further estimate revisions.
Source: tickerreport.com · dailypolitical.com
Neostellar Capital’s transformation and TTM Technologies’ record quarter reveal how AI infrastructure spending is reshaping investment portfolios and manufacturing margins, with key financial metrics pointing to fresh momentum for both companies.
Source: dailypolitical.com · themarketsdaily.com
USANA Health Sciences stunned the Street with fiscal 2026 earnings guidance of just $0.76 per share, 64% below consensus, and revenue of $910 million—following a quarterly loss of $0.07. With analyst consensus dropping to Reduce and the stock trading near its 52-week low, investors are reassessing valuation and downside risk.
Source: themarketsdaily.com · dailypolitical.com
Construction Partners (ROAD) posted a $0.07 EPS surprise and 28.2% revenue growth, yet analyst downgrades and price target cuts cloud the outlook. The stock's low PEG ratio of 0.85 contrasts with a high debt load and thin margins, creating a complex picture for value and growth investors.
Source: themarketsdaily.com · dailypolitical.com
Halozyme Therapeutics posted a massive Q2 beat and raised FY2026 EPS guidance to $8.65-$9.00, well above the $8.02 consensus, triggering a two-day stock surge past $103. With a forward P/E near 11.5x and a PEG ratio of 0.36, the market is repricing the stock after realizing the royalty growth was underestimated.
Commonwealth Bank of Australia reported a cash net profit of $11 billion, beating expectations, but CEO Matt Comyn cautioned that higher rates and tax changes are crimping household budgets and housing activity. The outlook is clouded by a 15-20% drop in mortgage applications across the banking sector and a hawkish RBA stance.
Alexandria Real Estate Equities shares climbed 3.2% to $53.08 after Q2 revenue of $662.78M beat estimates, even as EPS missed by $0.52. The FY 2026 EPS guidance of $6.35-$6.45 provides a stalwart midpoint against a choppy analyst landscape, while a 5.4% dividend yield offers a cushion for income investors.
Grand Canyon Education shares fell to $150.13 after Q3 EPS guidance of $1.74-$1.78 missed the $1.83 consensus. The company lifted its FY 2026 EPS outlook above expectations, creating a mixed investment signal. Analysts remain moderately bullish with a $171.67 consensus target.
Trump Media & Technology Group reported a $238 million quarterly loss, a tenfold increase, and scrapped its crypto and betting ventures. New CEO Kevin McGurn is pivoting to a controversial Truth API that sells early access to President Trump's posts to trading firms, raising regulatory and ethical flags.
Source: wtae.com · pilotonline.com
Ur-Energy's second quarter marked a turning point as record output and low costs solidified its position as the largest US ISR uranium producer, generating $14.4 million in sales with a $40.20/lb cash cost.
Source: tennesseedaily.com
Trump Media & Technology Group’s Q2 earnings reveal a catastrophic $238M loss, overwhelmingly driven by crypto declines, on a meager $1.7M in revenue. The company holds $1.9B in financial assets but faces regulatory and ethical headwinds with a new trading-advantage service.
Altius Minerals' attributable royalty revenue hit $30M, up 136% YoY, with adjusted EBITDA surging to $23.3M. Strong commodity prices and new lithium royalties drove the beat, while adjusted EPS quadrupled to $0.14, signaling robust cash flow generation.
Source: Business Wire (ca) · leaderpost.com
GameSquare Holdings reported Q2 2026 revenue of $18.5M, up 137% YoY, gross margin expanded to 49%, and adjusted EBITDA swung to a record $1M. The scale-driven improvement signals a path to sustainable profitability.
Source: hawaiitelegraph.com · finanznachrichten.de
Three London-listed mid-caps—Derwent London, Serco Group, and Hikma Pharmaceuticals—reported H1 results that collectively beat expectations and prompted guidance upgrades or reiteration. With rental growth at a decade high, defence spending flowing to outsourcers, and pharma injectables recovering, the results signal robust sectoral momentum despite geopolitical and macro risks.
Atlassian delivered a strong earnings beat and bullish guidance, directly challenging the bear thesis that AI would erode enterprise software value. Management said AI is boosting adoption, not threatening the business, triggering a sharp stock rally and potential sector-wide re-rating. Investors are now reassessing growth prospects for incumbent platforms integrating AI features.
Source: (us) · Faizan Farooque
Collegium Pharmaceutical delivered an 11.6% EPS beat and modest revenue beat, lifting shares to $29.47. High ROE and institutional accumulation offset by high leverage and mixed analyst ratings create a nuanced investment case.
According to our own tracking database, this category has accumulated 585 earnings stories since coverage began. This page aggregates the latest earnings stories within our finance coverage area. Every story is cross-referenced across multiple primary sources, scored for sentiment and operational impact, and timestamped so fresh developments surface first. We track quarterly results, guidance, estimates and surface the angles a domain expert would actually read.
Story selection follows our editorial methodology — impact scoring weights regulatory, financial, and operational developments distinctly. Sentiment is classified across five tiers via supervised classification trained on labeled industry corpora. See our glossary for term definitions and our trends index for longitudinal patterns across the finance beat.
Stories only surface on this page once the classifier scores them at a minimum 35 percent relevance to the category. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.
See something wrong on this page — a wrong stat, a broken source link, a miscategorized story? Report a data issue.
| Signal | What it tells you |
|---|---|
| Verified by N sources | Confidence the story isn't a single-source rumor — N≥2 means the development is independently corroborated. |
| Impact score (1-10) | Estimated regulatory, financial, or operational impact. 8+ indicates a story experienced operators should act on. |
| Sentiment | Five-tier classification (very bullish through very bearish) trained on labeled finance-specific corpora. |
| Time stamp | Recency. Fresh stories (under 1h) render with a highlighted timestamp; stale stories (≥24h) render dimmed. |